Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-18-064171
Filing Date
2018-10-26
Accepted
2018-10-26 16:19:33
Documents
1
Group Members
CHRISTOPH WESTPHAL, M.D., PH.D.LONGWOOD FUND II GP, LLCLONGWOOD FUND III GP, LLCLONGWOOD FUND III, L.P.RICHARD ALDRICH

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a18-37213_2sc13da.htm SC 13D/A 181431
  Complete submission text file 0001104659-18-064171.txt   183142
Mailing Address 800 BOYLSTON STREET SUITE 1555 BOSTON MA 02199
Business Address 800 BOYLSTON STREET SUITE 1555 BOSTON MA 02199 617-351-2590
Longwood Fund II, L.P. (Filed by) CIK: 0001543245 (see all company filings)

EIN.: 900792806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Subject) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88731 | Film No.: 181141839
SIC: 2834 Pharmaceutical Preparations